The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD

Copd Clinical Trial

Official title:

The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD: Randomised Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06286072
• Other study ID #: YCEYHANS
• Status: Recruiting
• Phase: N/A
• Start date: November 1, 2023
• Est. completion date: March 30, 2024

Study information

• Verified date: February 2024
• Source: Kirsehir Ahi Evran Universitesi
• Contact: Yasemin CEYHAN
• Phone: +905464589806
• Email: yasemin-ceyhan[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

COPD is an important respiratory system disease that progresses with damage to the airways.Increased mucus secretion and thickening in the airways causes obstruction.This obstruction causes symptoms such as shortness of breath, cough, phlegm and wheezing.The most obvious problem that the emerging symptoms will cause for the patient is fatigue.Coping with fatigue is an important problem in COPD.

The main questions it aims to answer are:

1. Does the training given in COPD affect the level of fatigue?

2. Do the education given and text messages sent regarding COPD affect the level of fatigue?

In this study, patients were given informative education about COPD and ways to cope with fatigue were explained. Then, in order to increase the permanence of the training, motivational messages and short briefings were continued for 8 weeks.2 messages were sent per week. Three groups were created to reveal the effectiveness of the trainings and messages.

Group 1 was trained and messages were sent for 8 weeks. Group 2 was trained and no message was sent. Group 3 is the control group. No training has been provided other than routine maintenance.

The initial information of all groups was taken again at the end of the 8th week.

Main outcomes:

• Dyspnea severity,

• COPD general conditions and

• Fatigue level. The results obtained will be interpreted by comparing between 3 groups.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: March 30, 2024
• Est. primary completion date: January 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Diagnosed with COPD for the last 1 year

• Hospitalized for at least 3 days,

• Voluntary patients

Exclusion Criteria:

• Under 18 years old

• Over 85 years old

• Those with chronic fatigue syndrome

• Those with severe heart failure

• Those who had surgery in the last 6 months

Related Conditions & MeSH terms

• Copd
• Fatigue

Intervention

Other:
• Education and message
COPD general education content and fatigue-specific coping strategies. Messages sent to phones

Locations

Country	Name	City	State
Turkey	Yasemin CEYHAN	Kirsehir	Center

Sponsors (1)

Lead Sponsor	Collaborator
Kirsehir Ahi Evran Universitesi

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Fatigue Level	Evaluated with COPD ASTHMA FATIGUE SCALE.	Applied at baseline and after 8 weeks.
Primary	Dyspnea Severity	Evaluated with mMRC Dyspnea Scale	Applied at baseline and after 8 weeks.
Secondary	COPD general condition	Evaluated with COPD ASSESSMENT QUESTIONNAIRE (CAT)	Applied at baseline and after 8 weeks.